Gene: ZFP36
Official Full Name: ZFP36 ring finger proteinprovided by HGNC
Gene Summary: Enables several functions, including 14-3-3 protein binding activity; heat shock protein binding activity; and mRNA 3'-UTR AU-rich region binding activity. Involved in several processes, including cellular response to cytokine stimulus; cellular response to epidermal growth factor stimulus; and regulation of gene expression. Acts upstream of or within mRNA catabolic process. Located in cytoplasmic ribonucleoprotein granule; cytosol; and nucleus. Part of ribonucleoprotein complex. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09621 | ZFP36 Knockout cell line (HeLa) | Human | ZFP36 | 1:3~1:6 | Negative | Online Inquiry |
KO09622 | ZFP36 Knockout cell line (HCT 116) | Human | ZFP36 | 1:2~1:4 | Negative | Online Inquiry |
KO09623 | ZFP36 Knockout cell line (HEK293) | Human | ZFP36 | 1:3~1:6 | Negative | Online Inquiry |
KO09624 | ZFP36 Knockout cell line (A549) | Human | ZFP36 | 1:3~1:4 | Negative | Online Inquiry |
ZFP36 Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the ZFP36 gene, which encodes a zinc-finger protein involved in regulating mRNA stability and degradation. These knockout cell lines have been developed through precise gene editing techniques, leading to a complete disruption of the ZFP36 gene, thereby providing a platform to investigate the downstream effects of ZFP36 loss on various cellular processes, including inflammation, cell proliferation, and apoptosis.
The primary function of ZFP36 is to bind to AU-rich elements (AREs) in the 3' untranslated regions of target mRNAs, promoting their decay. By utilizing ZFP36 Gene Knockout Cell Lines, researchers can analyze alterations in mRNA stability and translation for genes that are pivotal in various biological pathways. This creates an invaluable resource for understanding how post-transcriptional regulation influences gene expression profiles under physiologically relevant conditions.
In both research and clinical settings, the ZFP36 Gene Knockout Cell Lines hold significant importance as they shed light on the role of mRNA decay in disorders such as cancer, autoimmune diseases, and metabolic syndromes. Investigators can employ these models to assess therapeutic interventions, delve into the mechanistic underpinnings of diseases, and even develop novel biomarkers.
What sets our ZFP36 Gene Knockout Cell Lines apart from alternative models is their rigorously validated knockout efficiency, coupled with consistent performance across multiple applications, such as CRISPR screening and gene expression analysis. Our product offers researchers an efficient and reproducible means to study the impacts of the ZFP36 gene in a controlled setting.
Utilizing ZFP36 Gene Knockout Cell Lines not only enables deeper insights into the regulatory networks underlying many diseases but also expedites the translational research process, providing a step towards potential therapeutic advancements. Our company is committed to delivering high-quality biological products backed by extensive expertise in genetic engineering, allowing researchers and clinicians to explore the frontiers of molecular biology with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.